Incidental Prostate Cancer (cT1a–cT1b) Is a Relevant Clinical and Research Entity and Should Be Fully Discussed in the International Prostate Cancer Guidelines-Reference-Cited by-同舟云学术

Incidental Prostate Cancer (cT1a–cT1b) Is a Relevant Clinical and Research Entity and Should Be Fully Discussed in the International Prostate Cancer Guidelines

Published:2021-04 Issue: Volume: Page:
ISSN:2588-9311
Container-title:European Urology Oncology
language:en
Short-container-title:European Urology Oncology

Author:

Capitanio Umberto,Autorino Riccardo,Bandini Marco,Briganti Alberto,Cheng Liang,Cooperberg Matthew R.,Dehò Federico,Gallina Andrea,Klotz Laurence,Lane Brian,Montironi Rodolfo,Salonia Andrea,Stief Christian,Tombal Bertrand,Montorsi Francesco

Publisher

Elsevier BV

Subject

Urology,Radiology Nuclear Medicine and imaging,Oncology,Surgery

Reference16 articles.

1. NCCN Clinical practice guidelines in oncology - prostate cancer, version 2.2019 short;Mohler;J Natl Compr Cancer Netw,2019

2. Clinically localized prostate cancer: AUA/ASTRO/SUO guideline. Part I: risk stratification, shared decision making, and care options;Sanda;J Urol,2018

3. The role of multiparametric magnetic resonance imaging in active surveillance for men with low-risk prostate cancer: a cost-effectiveness modeling study;Patel;Eur Urol Oncol,2018

4. Temporal trend in incidental prostate cancer detection at surgery for benign prostatic hyperplasia;Capogrosso;Urology,2018

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oncologic Outcomes of Incidental Versus Biopsy-diagnosed Grade Group 1 Prostate Cancer: A Multi-institutional Study;European Urology Open Science;2024-10

2. Return on investment in science: twenty years of European Commission funded research in Alzheimer’s dementia, breast cancer and prostate cancer;Cost Effectiveness and Resource Allocation;2024-06-16

3. Benign prostatic hyperplasia during active surveillance for prostate cancer: is it time to define management strategies?;Prostate Cancer and Prostatic Diseases;2024-04-29

4. Contemporary validation of cT1a vs. cT1b substaging of incidental prostate cancer;World Journal of Urology;2024-04-28

5. Incidental Prostate Cancer in Patients Treated for Benign Prostatic Hyperplasia: Analysis from a Contemporary National Dataset;Diagnostics;2024-03-23